Biomarkers for Alzheimer Disease: Classical and Novel Candidates' Review

被引:73
|
作者
El Kadmiri, Nadia [1 ,2 ]
Said, Nadia [4 ]
Slassi, Ilham [2 ,3 ]
El Moutawakil, Bouchra [2 ,3 ]
Nadifi, Sellama [2 ]
机构
[1] IBN ZOHR Univ, LBVE, Polydisciplinary Fac Taroudant, BP 271, Taroudant 83000, Morocco
[2] Hassan II Univ Casablanca, Lab Med Genet & Mol Pathol, Fac Med & Pharm, BP 9154, Casablanca 9154, Morocco
[3] IBN ROCHD Univ Hosp, Dept Neurol, Casablanca, Morocco
[4] Hassan II Univ Casablanca, Pharmacol Lab, Fac Med & Pharm, BP 9154, Casablanca, Morocco
关键词
biomarkers; diagnosis; Alzheimer's disease; MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; CEREBROSPINAL-FLUID; CSF BIOMARKERS; FOLLOW-UP; FDG-PET; PLASMA; A-BETA-42; DEMENTIA; MARKERS;
D O I
10.1016/j.neuroscience.2017.07.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The biomarkers may be useful for predictive diagnosis of Alzheimer's disease (AD). The current challenge is to diagnose it in its preclinical phase. The combination of cerebrospinal fluid (CSF) biomarkers and imaging has been investigated extensively for a number of years. It can provide an increased diagnostic accuracy. This review discusses the contribution of classical biomarkers to predict AD and highlights novel candidates identified as potential markers for AD. We referred to the electronic databases PubMed/Medline and Web of Science to search for articles that were published until February 2016. Sixty-two records were included in qualitative synthesis. In the first section, the results show the contribution of biomarkers to predict and track AD considered as classical biomarkers. In the second section, the results highlight the involvement of novel candidates that should be considered for future evaluation in the characterization of the AD progression. Reported findings open prospect to define noninvasive biomarkers to predict AD before symptoms onset. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 50 条
  • [41] Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review
    Wu, Helen Zong Ying
    Ong, Kwok Leung
    Seeher, Katrin
    Armstrong, Nicola J.
    Thalamuthu, Anbupalam
    Brodaty, Henry
    Sachdev, Perminder
    Mather, Karen
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 49 (03) : 755 - 766
  • [42] A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer's Disease
    Bouftas, M.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2021, 8 (01): : 84 - 91
  • [43] Biomarkers for Alzheimer's Disease in the Current State: A Narrative Review
    Gunes, Serafettin
    Aizawa, Yumi
    Sugashi, Takuma
    Sugimoto, Masahiro
    Rodrigues, Pedro Pereira
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [44] EEG and ERP biomarkers of Alzheimer's disease: a critical review
    Horvath, Andras
    Szucs, Anna
    Csukly, Gabor
    Sakovics, Anna
    Stefanics, Gabor
    Kamondi, Anita
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 183 - 220
  • [45] Research progress on humoral biomarkers of Alzheimer's disease: A review
    Zhang, Hao
    Fu, Xiaofeng
    Yang, Mengyu
    Song, Xiaowen
    Li, Min
    Wang, Xuezhen
    MEDICINE, 2024, 103 (30)
  • [46] Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease
    Son, Minky
    Park, Chanin
    Rampogu, Shailima
    Zeb, Amir
    Lee, Keun Woo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04)
  • [47] Identification of tetrahydrocarbazoles as novel multifactorial drug candidates for treatment of Alzheimer’s disease
    K Honarnejad
    A Daschner
    A P Gehring
    A Szybinska
    A Giese
    J Kuznicki
    F Bracher
    J Herms
    Translational Psychiatry, 2014, 4 : e489 - e489
  • [48] Identification of tetrahydrocarbazoles as novel multifactorial drug candidates for treatment of Alzheimer's disease
    Honarnejad, K.
    Daschner, A.
    Gehring, A. P.
    Szybinska, A.
    Giese, A.
    Kuznicki, J.
    Bracher, F.
    Herms, J.
    TRANSLATIONAL PSYCHIATRY, 2014, 4 : e489 - e489
  • [49] Discovery of Novel Drug Candidates for Alzheimer's Disease by Molecular Network Modeling
    Zhou, Jiaxin
    Li, Qingyong
    Wu, Wensi
    Zhang, Xiaojun
    Zuo, Zhiyi
    Lu, Yanan
    Zhao, Huiying
    Wang, Zhi
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [50] Novel blood test for early biomarkers of preeclampsia and Alzheimer's disease
    Cheng, Shibin
    Banerjee, Sayani
    Daiello, Lori A.
    Nakashima, Akitoshi
    Jash, Sukanta
    Huang, Zheping
    Drake, Jonathan D.
    Ernerudh, Jan
    Berg, Goran
    Padbury, James
    Saito, Shigeru
    Ott, Brian R.
    Sharma, Surendra
    SCIENTIFIC REPORTS, 2021, 11 (01)